Thematic Insights Future Health
Alzheimer's Disease: A New Era of Treatment
Alzheimer’s is estimated to be the most costly disease in the US, surpassing cancer and heart disease. Given aging populations and the number of people suffering from it, a treatment for the underlying cause of this condition would represent a breakthrough with positive implications for society.
Recently, there have been developments in the treatment Alzheimer’s that may also impact positively not only biopharma companies, but also contract drug manufacturers and bioprocessing equipment makers.
Find out more about investment opportunities in this sector in our latest Thematic Insight on future health trends.